semaglutide news oct 26 2025 The NHS will soon offer the weight‑loss medication Wegovy to more than 1 million people with cardiovascular disease to help prevent deadly heart attacks and strokes. Clinical trials show that semaglutide, the Medicare negotiated lower prices for

Most importantly, do not discontinue your medication without medical guidance, as symptoms often improve with continued use and appropriate management strategies

Food and Drug Administration approval of semaglutide (Ozempic) to reduce the risk of kidney disease progression, kidney failure, and cardiovascular death in adults with type 2 diabetes (T2D) and chronic kidney disease (CKD), its impact on clinical practice is becoming increasingly evident

When combined with appropriate testosterone optimization, IGF-1 can amplify the benefits of both therapies

Non-destructive determination of malondialdehyde (MDA) distribution in oilseed rape leaves by laboratory scale NIR hyperspectral imaging

Semaglutide reduces appetite and makes the patient feel fuller faster

Providing wrap-around support for nutrition, behavior change, and mental health GLP-1 medications are approved for chronic weight management only as an adjunct to diet and exercisenot as quick fixes that cure obesity after a few doses